Cencora Net Income 2010-2024 | COR
Cencora annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Cencora net income for the quarter ending September 30, 2024 was $0.003B, a 99.04% decline year-over-year.
- Cencora net income for the twelve months ending September 30, 2024 was $1.509B, a 13.53% decline year-over-year.
- Cencora annual net income for 2024 was $1.509B, a 13.53% decline from 2023.
- Cencora annual net income for 2023 was $1.745B, a 2.74% increase from 2022.
- Cencora annual net income for 2022 was $1.699B, a 10.32% increase from 2021.
| Cencora Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $1,509 |
| 2023 | $1,745 |
| 2022 | $1,699 |
| 2021 | $1,540 |
| 2020 | $-3,409 |
| 2019 | $855 |
| 2018 | $1,658 |
| 2017 | $364 |
| 2016 | $1,428 |
| 2015 | $-138 |
| 2014 | $274 |
| 2013 | $434 |
| 2012 | $719 |
| 2011 | $707 |
| 2010 | $637 |
| 2009 | $503 |
| Cencora Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $3 |
| 2024-06-30 | $483 |
| 2024-03-31 | $421 |
| 2023-12-31 | $602 |
| 2023-09-30 | $351 |
| 2023-06-30 | $480 |
| 2023-03-31 | $435 |
| 2022-12-31 | $480 |
| 2022-09-30 | $295 |
| 2022-06-30 | $407 |
| 2022-03-31 | $548 |
| 2021-12-31 | $449 |
| 2021-09-30 | $438 |
| 2021-06-30 | $292 |
| 2021-03-31 | $435 |
| 2020-12-31 | $375 |
| 2020-09-30 | $-4,846 |
| 2020-06-30 | $289 |
| 2020-03-31 | $960 |
| 2019-12-31 | $188 |
| 2019-09-30 | $133 |
| 2019-06-30 | $302 |
| 2019-03-31 | $27 |
| 2018-12-31 | $394 |
| 2018-09-30 | $233 |
| 2018-06-30 | $276 |
| 2018-03-31 | $287 |
| 2017-12-31 | $862 |
| 2017-09-30 | $-345 |
| 2017-06-30 | $50 |
| 2017-03-31 | $411 |
| 2016-12-31 | $247 |
| 2016-09-30 | $146 |
| 2016-06-30 | $349 |
| 2016-03-31 | $603 |
| 2015-12-31 | $330 |
| 2015-09-30 | $361 |
| 2015-06-30 | $214 |
| 2015-03-31 | $-513 |
| 2014-12-31 | $-200 |
| 2014-09-30 | $66 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $180 |
| 2013-12-31 | $41 |
| 2013-09-30 | $51 |
| 2013-06-30 | $168 |
| 2013-03-31 | $46 |
| 2012-12-31 | $169 |
| 2012-09-30 | $163 |
| 2012-06-30 | $181 |
| 2012-03-31 | $212 |
| 2011-12-31 | $162 |
| 2011-09-30 | $147 |
| 2011-06-30 | $184 |
| 2011-03-31 | $214 |
| 2010-12-31 | $161 |
| 2010-09-30 | $141 |
| 2010-06-30 | $163 |
| 2010-03-31 | $181 |
| 2009-12-31 | $151 |
| 2009-09-30 | $130 |
| 2009-06-30 | $119 |
| 2009-03-31 | $143 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $48.280B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| Revvity (RVTY) | United States | $13.634B | 23.68 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |